How to manage MAC lung disease in a female?

Question

Hello doctor,

My 48-year-old mother has Mycobacterium avium complex (MAC) lung disease, and it has been very difficult to treat. She has been on triple antibiotic therapy with Azithromycin, Ethambutol, and Rifampin for eight months, but she is still having symptoms. Her chest CT scan shows persistent cavitary lesions, and her sputum cultures remain positive.

She has lost twenty-five pounds and experiences constant fatigue. The pulmonologist mentioned that women, especially after menopause, are more prone to MAC infections. She has also developed hearing loss from Ethambutol, which is affecting her ability to work. The medications cause significant nausea, and she struggles to keep food down. A recent bone density scan showed osteoporosis, which may be related to the chronic infection.

Why are women more susceptible to MAC lung disease, and are there alternative treatments that might be easier to tolerate? Please help.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com

I have read your query and understand your concern. I am truly sorry for what your mother is going through.

Women, particularly after menopause, are indeed more prone to this infection. Several factors contribute to this increased risk. Changes in female hormones over time affect immune responses in the lungs and reduce protection against slow-growing organisms such as Mycobacterium avium complex (MAC), which is a group of environmental bacteria that primarily affects the lungs and causes chronic infection. Lower body weight, loss of muscle mass, and reduced cough strength, all of which can worsen with chronic illness, further increase vulnerability. This condition is not related to hygiene or exposure, and it is not something she caused.

When MAC lung disease persists despite standard treatment, it does not mean that therapy has failed, but it does indicate that adjustments may be needed. In patients who have cavitary lesions on chest computed tomography (CT) scans and ongoing positive sputum cultures, treatment often needs to be intensified or modified rather than discontinued. If one medication is causing significant toxicity, especially affecting hearing or vision, experienced physicians may substitute or rebalance medications rather than continue treatment that causes harm. In selected cases, newer or alternative antibiotics are used, sometimes with modified dosing schedules, to improve tolerance while still suppressing the infection.

The weight loss, nausea, and fatigue you describe are very common and are just as important to address as the infection itself. Poor nutrition weakens the immune system and slows recovery, so managing treatment-related side effects aggressively is a core part of care. Bone loss can occur in chronic lung infections due to ongoing inflammation, reduced physical activity, low body weight, and prolonged illness, rather than the bacteria alone. Addressing nutrition, vitamin deficiencies, and physical strength can meaningfully support recovery alongside antibiotic therapy.

This is a condition that benefits from care at a center experienced in non-tuberculous Mycobacterial lung disease, where treatment can be individualized rather than rigid. With appropriate adjustments, many patients do stabilize and improve, even after a difficult first year.

I hope this answers your questions. Please feel free to follow up if you need any further clarification or support.

Thank you.